<DOC>
	<DOCNO>NCT01695902</DOCNO>
	<brief_summary>The primary objective study compare efficacy Test Product ( Levosert ) vs. Reference Product ( Mirena® Bayer-Schering ) base mean variation menstrual blood loss volume woman menorrhagia . The secondary objective include physical gynaecological examination , vital sign , clinical laboratory test include hemoglobin ferritin measurement , body weight spontaneously report adverse event analyse compare Levosert Mirena® treatment arm . Plasma level levonorgestrel ( LNG ) also evaluate various period time . The residual amount LNG device finally measure withdrawal completion study . Plasma level LNG residual amount LNG compare two treatment group . Contraceptive effect Levosert estimate Pearl Index .</brief_summary>
	<brief_title>Therapeutic Equivalence Trial Two Hormonal-IUDs Patients With Heavy Menstrual Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Nonpregnant , nonplanning pregnancy , nonlactating nonmenopausal female least 18 year age . Patients clinical diagnosis functional Menorrhagia last 6 month . Patients eligible able participate trial consent write purpose nature investigation explain . History endometrial ablation dilatation and/or curettage within 3 month prior screen Copper coiledintrauterine device LNG release IUS use within 2 month prior screen Abnormal liver function jaundice Renal insufficiency Other hormonal treatment ( sexual steroid ) , Organic cause abnormal uterine bleeding ( presence endometrial polyp , submucous myoma size , myometrial myoma &gt; 3 cm , adenomyosis , atypical hyperplasia , carcinoma ) Abnormal uterine morphology Presence ovarian cyst &gt; 3 cm Lower genital tract infection Current recurrent PID ( present recurrent pelvis infection ( include history postpartum endometritis , infected miscarriage ) past 3 month Uncontrolled hypertension Congenital acquire valvular disease ( include correction prosthetic valve ) Known suspected pregnancy Known suspect hormonedependent tumor BMI &gt; 30 Abnormal Pap smear test evidence cervical/endometrial mancy Unexplained amenorrhea Known hypersensitivity device material and/or Levonorgestrel</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>